The FDA has approved a new injectable form of the multiple sclerosis drug ocrelizumab for use in adults with relapsing and progressive forms of the disease.

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...

Drug companies are under fire for the high cost of Ozempic and simlar meds. A doctor said patients who can't afford it may get riskier online versions.

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

James Corden revealed that he gave Ozempic a try to help with weight loss, but soon found that his relationship with food had little to do with how hungry he was or wasn't.

The effectiveness can vary based on the individual response and adherence to treatment. Research indicates that GLP-1 ...

An emerging market for compounded weight loss injections that mimic brand-name drugs such as Ozempic, Wegovy, Mounjaro and ...

During a week-long joint operation between U.S. Food and Drug Administration (FDA) and U.S. Customs and Border Protection ...

Despite being patented products without any approved generics, sky-high demand for GLP-1 drugs like Ozempic and Mounjaro has ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

While Congress debates the high cost of brand-name diabetes and weight loss drugs, Atlanta doctors are selling lower-cost alternatives made by compounding pharmacies.